Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Colin Vicente
Observed names:
C Vicente,
C. Vicente,
Vicente, Colin
Institution:
General Electric (Canada)
Observed institutions:
University of Toronto,
Brock University,
General Electric (Canada),
Institute of Ophthalmology,
PharmIdeas (Canada),
Walker (United States)
show all 6
ORCID:
0000-0002-2940-1743
Observed ORCID:
0000-0002-2940-1743
OpenAlex ID:
A5067553502
Methicillin‐Resistant Staphylococcus aureus : A Public Health Issue with Economic Consequences
2006
·
Mireille Goetghebeur
, Pierre-Alexandre Landry
, et al.
·
Canadian Journal of Infectious Diseases and Medical Microbiology
·
120
PDF
Economic burden of nausea and vomiting of pregnancy in the USA.
2013
·
Charles Piwko
, Gideon Koren
, et al.
·
PubMed
·
82
Cost of Glaucoma in Canada: Analyses Based on Visual Field and Physician's Assessment
2003
·
Michael Iskedjian
, John Walker
, et al.
·
Journal of Glaucoma
·
73
Economic evaluation of Avonex® (interferon beta-1a) in patients following a single demyelinating event
2005
·
Michael Iskedjian
, John H Walker
, et al.
·
Multiple Sclerosis Journal
·
32
The cost-effectiveness of delayed-release dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis in Canada
2016
·
Wenqing Su
, Anuraag Kansal
, et al.
·
Journal of Medical Economics
·
28
PDF
Pharmacoeconomics of depot antipsychotics for treating chronic schizophrenia in Sweden
2013
·
Thomas R. Einarson
, Colin Vicente
, et al.
·
Nordic Journal of Psychiatry
·
28
Pharmacoeconomic analysis of paliperidone palmitate for treating schizophrenia in Greece
2012
·
Thomas R Einarson
, Maria Geitona
, et al.
·
Annals of General Psychiatry
·
28
PDF
Quality assessment of meta-analyses of RCTs of pharmacotherapy in major depressive disorder
2004
·
Michiel E. H. Hemels
, Colin Vicente
, et al.
·
Current Medical Research and Opinion
·
23
Screening for glaucoma in Canada: a systematic review of the literature
2006
·
Thomas R. Einarson
, Colin Vicente
, et al.
·
Canadian Journal of Ophthalmology
·
21
The STARRT trial: a cost comparison of optimal vs sub-optimal initiation of dialysis in Canada
2011
·
Charles Piwko
, Colin Vicente
, et al.
·
Journal of Medical Economics
·
20
PDF
The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada
2021
·
Mohsen Sadatsafavi
, J. Mark FitzGerald
, et al.
·
Allergy Asthma and Clinical Immunology
·
19
PDF
Cost-effectiveness analysis of atypical long-acting antipsychotics for treating chronic schizophrenia in Finland
2013
·
Thomas R. Einarson
, Hanna Pudas
, et al.
·
Journal of Medical Economics
·
18
Pharmacoeconomic analysis of paliperidone palmitate versus olanzapine pamoate for chronic schizophrenia in Norway
2012
·
Thomas R. Einarson
, Colin Vicente
, et al.
·
Acta Neuropsychiatrica
·
18
Cost-minimization analysis of treprostinil vs. epoprostenol as an alternate to oral therapy non-responders for the treatment of pulmonary arterial hypertension
2005
·
L. Narine
, L. K. Hague
, et al.
·
Current Medical Research and Opinion
·
18
Cost‐Effectiveness of Treprostinil Versus Epoprostenol in Patients with Pulmonary Arterial Hypertension: A Canadian Analysis
2005
·
Thomas R Einarson
, John T Granton
, et al.
·
Canadian Respiratory Journal
·
13
PDF
Association between mean intraocular pressure, disease stability and cost of treating glaucoma in Canada
2004
·
Colin Vicente
, John Walker
, et al.
·
Current Medical Research and Opinion
·
13
The Cost Effectiveness of Axicabtagene Ciloleucel Versus Best Supportive Care in the Treatment of Adult Patients with Relapsed or Refractory Large B-Cell Lymphoma (LBCL) After Two or More Lines of Systemic Therapy in Canada
2022
·
Christopher Hillis
, Colin Vicente
, et al.
·
PharmacoEconomics
·
9
Association between corneal thickness, mean intraocular pressure, disease stability and severity, and cost of treatment in glaucoma: a Canadian analysis
2005
·
John H. Walker
, Yvonne Buys
, et al.
·
Current Medical Research and Opinion
·
5
Cost-Utility Analysis of Enzalutamide for Patients with Previously Treated Metastatic Castration-Resistant Prostate Cancer (MCRPC)
2014
·
C. Vicente
, V. Babashov
, et al.
·
Value in Health
·
1
PDF
Pharmacoeconomic analysis of paliperidone palmitate for chronic relapsing schizophrenia in Finland
2014
·
H. Pudas
, R. Jensen
, et al.
·
Value in Health
·
1
Cost-Utility Analysis Of Tocilizumab In The Treatment Of Active Systemic Juvenile Idiopathic Arthritis
2013
·
C. Vicente
, S. Sabapathy
, et al.
·
Value in Health
·
1
PMH35 A Cost-Effectiveness Analysis of Paliperidone Palmitate Versus Olanzapine Pamoate in the Treatment of Schizophrenia in Norway
2011
·
T.R. Einarson
, C. Vicente
, et al.
·
Value in Health
·
1
Pey8 Economic Evaluation of Early Treatment for Patients With Primary Open Angle Glaucoma
2006
·
C Vicente
, P Grootendorst
, et al.
·
Value in Health
·
1
PDF
Venetoclax in Combination with Obinutuzumab in Previously Untreated Fit Patients with Chronic Lymphocytic Leukemia: A Canadian Cost-Utility Analysis
2025
·
Gijs van de Wetering
, Carolyn Owen
, et al.
·
PharmacoEconomics - Open
PDF
A Canadian Cost-Utility Analysis of Epcoritamab Versus Current Therapies in Third-Line or Later Large B-Cell Lymphoma
2024
·
Shivani Kamdar
, David Macdonald
, et al.
·
Blood
Show more works
View as search
Works count:
36
Citation count:
573
H-index:
14
I10-index:
16
Year
Topic
Type
